QA: Bioxytran INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2020_Bioxytran_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001445815, Bioxytran INC

  xvar xval
0 AssetsCurrent 219,628
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,018,915
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 488,740
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 1,107,570
11 remainder_Revenues 0
12 remainder_NetIncome -182,133
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 219,628
1 Liabilities 1,018,915
2 Expenses 1,596,310
3 Revenues 0
4 StockholdersEquity -799,287
5 NetIncome -1,778,443
6 ComprehensiveNetIncome -1,778,443
7 BaseVar 1,508,493
8 EconomicCapitalRatiobeforeLimitedLiability -5.69
9 EconomicCapitalRatio 0.106

Edgar->Model Mapping

Feature Distribution

Change over Time